Edition:
United States

Lexicon Pharmaceuticals Inc (LXRX.OQ)

LXRX.OQ on NASDAQ Stock Exchange Global Select Market

8.53USD
15 Oct 2018
Change (% chg)

-- (--)
Prev Close
$8.53
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
171,824
52-wk High
$13.97
52-wk Low
$7.68

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 13.75 -0.328
Mar '18 25.21 -0.398
FY 2017 Dec '17 33.05 -0.307
Sep '17 26.94 -0.291
Jun '17 12.05 -0.333
Mar '17 18.29 -0.334
FY 2016 Dec '16 23.04 -0.312
Sep '16 27.72 -0.347
Jun '16 20.09 -0.367
Mar '16 12.49 -0.336
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 14.29 18.90 11.80 41.30
Quarter Ending Mar-19 2 43.55 62.10 25.00 63.20
Year Ending Dec-18 6 66.34 74.20 60.80 140.60
Year Ending Dec-19 6 207.84 271.00 129.00 270.12
Earnings (per share)
Quarter Ending Dec-18 6 -0.35 -0.26 -0.39 -0.19
Quarter Ending Mar-19 2 -0.11 0.02 -0.24 0.09
Year Ending Dec-18 7 -1.38 -1.21 -1.47 -0.96
Year Ending Dec-19 7 -0.00 0.39 -0.55 0.04
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 119.85 32.14
P/E High - Last 5 Yrs. -- 284.29 46.82
P/E Low - Last 5 Yrs. -- 95.75 24.71
Beta 0.40 0.63 0.87
Price to Sales (TTM) 9.98 109.82 6.55
Price to Book (MRQ) -- 13.72 4.00
Price to Tangible Book (MRQ) -- 20.21 6.10
Price to Cash Flow (TTM) -- 69.50 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.20 1.45
Dividend 5 Year Growth Rate -- 2.61 -5.91
Payout Ratio(TTM) -- 5.68 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 14.10 157.56 7.91
Sales (TTM) vs TTM 1 Yr. Ago 22.01 91.25 6.56
Sales - 5 Yr. Growth Rate 141.97 25.47 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago 1.52 297.15 26.63
EPS (TTM) vs TTM 1 Yr. Ago 0.11 -- --
EPS - 5 Yr. Growth Rate -- 25.12 7.65
Capital Spending - 5 Yr. Growth Rate -14.26 39.11 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.68 1.65 2.22
Current Ratio (MRQ) 2.71 5.52 2.99
LT Debt to Equity (MRQ) -- 15.33 11.31
Total Debt to Equity (MRQ) -- 18.80 14.15
Interest Coverage (TTM) -22.01 -216.32 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 97.47 32.64 54.36
Gross Margin - 5 Yr. Avg. -- 52.76 53.16
EBITD Margin (TTM) -126.33 -- --
EBITD - 5 Yr. Avg -134.36 -164.07 16.13
Operating Margin (TTM) -130.07 -618.88 3.36
Operating Margin - 5 Yr. Avg. -144.51 -178.92 11.28
Pre-Tax Margin (TTM) -141.38 -615.68 3.79
Pre-Tax Margin - 5 Yr. Avg. -149.75 -181.48 11.54
Net Profit Margin (TTM) -141.37 -604.79 0.60
Net Profit Margin - 5 Yr. Avg. -147.09 -179.91 7.83
Effective Tax Rate (TTM) -- 11.98 20.73
Effective Tax Rate - 5 Yr. Avg. -- 19.65 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 568,672 24,741,437 725,680,242
Net Income/Employee (TTM) -803,914 1,102,410 84,001,075
Receivable Turnover (TTM) 21.01 4.18 5.06
Inventory Turnover (TTM) 1.70 2.14 3.65
Asset Turnover (TTM) 0.28 0.39 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -40.17 0.35 9.83
Return on Assets - 5 Yr. Avg. -21.24 3.11 10.94
Return on Investment (TTM) -58.05 1.96 12.83
Return on Investment - 5 Yr. Avg. -26.08 2.91 14.05
Return on Equity (TTM) -276.33 1.12 14.95
Return on Equity - 5 Yr. Avg. -45.76 -0.97 15.39
  1 Year 3 Year 5 Year
Sales % 8.40 58.11 141.97
EPS (TTM) % 7.15 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Lexicon Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -14.17 -14.38 28 59
13 Week -24.70 -27.31 24 76
26 Week 10.41 0.03 69 56
52 Week -20.53 -29.76 45 83
YTD -5.57 -12.47 53 84
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 180
Total Shares Held: 111,044,887
3 Mo. Net Change: 300,123
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 14
# Reduced Positions: 5
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.